These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 31738147)

  • 21. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29.
    Li Y; Wang F; Xu J; Ye F; Shen Y; Zhou J; Lu W; Wan X; Ma D; Xie X
    J Pathol; 2011 Aug; 224(4):484-95. PubMed ID: 21503900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus vaccine: a new chance to prevent cervical cancer.
    Monk BJ; Mahdavi A
    Recent Results Cancer Res; 2007; 174():81-90. PubMed ID: 17302188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes.
    Wu Z; Li TY; Jiang M; Yu L; Zhao J; Wang H; Zhang X; Chen W; Qiao Y
    Cancer Prev Res (Phila); 2019 Feb; 12(2):95-102. PubMed ID: 30606718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
    Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
    Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
    Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications.
    Gómez-Gómez Y; Organista-Nava J; Gariglio P
    Biomed Res Int; 2013; 2013():407052. PubMed ID: 24490161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
    Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
    Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.
    McKeage K; Romanowski B
    Drugs; 2011 Mar; 71(4):465-88. PubMed ID: 21395359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
    Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
    BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection.
    Asiaf A; Ahmad ST; Mohammad SO; Zargar MA
    Eur J Cancer Prev; 2014 May; 23(3):206-24. PubMed ID: 24129107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA as viral transcription tuners in HPV-mediated cervical carcinogenesis.
    Shishodia G; Verma G; Das BC; Bharti AC
    Front Biosci (Schol Ed); 2018 Jan; 10(1):21-47. PubMed ID: 28930517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
    Kind AB; Pavelyev A; Kothari S; El Mouaddin N; Schmidt A; Morais E; Guggisberg P; Lienert F
    BMC Public Health; 2020 May; 20(1):671. PubMed ID: 32398057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials of human papillomavirus vaccines and beyond.
    Lehtinen M; Dillner J
    Nat Rev Clin Oncol; 2013 Jul; 10(7):400-10. PubMed ID: 23736648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten years of HPV vaccines: State of art and controversies.
    Angioli R; Lopez S; Aloisi A; Terranova C; De Cicco C; Scaletta G; Capriglione S; Miranda A; Luvero D; Ricciardi R; Montera R; Plotti F
    Crit Rev Oncol Hematol; 2016 Jun; 102():65-72. PubMed ID: 27066937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current research into novel therapeutic vaccines against cervical cancer.
    Cordeiro MN; De Lima RCP; Paolini F; Melo ARDS; Campos APF; Venuti A; De Freitas AC
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):365-376. PubMed ID: 29475377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.